RASON Trademark

Trademark Overview


On Wednesday, August 23, 2000, a trademark application was filed for RASON with the United States Patent and Trademark Office. The USPTO has given the RASON trademark a serial number of 76122112. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, May 16, 2009. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The RASON trademark is filed in the Pharmaceutical Products category with the following description:

Describing pharmaceutical preparations for administration via respiratory airways, namely nucleotide sequences for medical use or Respiratory Anti-Sense OligoNucleotides (RASON), including aerosolized oligonucleotide preparations for the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, particularly testing, preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, ...
rason

General Information


Serial Number76122112
Word MarkRASON
Filing DateWednesday, August 23, 2000
Status710 - CANCELLED - SECTION 8
Status DateSaturday, May 16, 2009
Registration Number2614111
Registration DateTuesday, September 3, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2002

Trademark Statements


Goods and ServicesDescribing pharmaceutical preparations for administration via respiratory airways, namely nucleotide sequences for medical use or Respiratory Anti-Sense OligoNucleotides (RASON), including aerosolized oligonucleotide preparations for the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, particularly testing, preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg cancers which metastasized to the lung(s), breast, liver and prostate included

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, May 16, 2009
Primary Code005
First Use Anywhere DateThursday, August 31, 1995
First Use In Commerce DateThursday, November 30, 1995

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Saturday, May 16, 2009CANCELLED SEC. 8 (6-YR)
Thursday, September 27, 2007CASE FILE IN TICRS
Tuesday, September 3, 2002REGISTERED-PRINCIPAL REGISTER
Tuesday, June 11, 2002PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2002NOTICE OF PUBLICATION
Wednesday, February 6, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 10, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2001NON-FINAL ACTION MAILED
Wednesday, January 24, 2001ASSIGNED TO EXAMINER
Wednesday, January 24, 2001ASSIGNED TO EXAMINER
Tuesday, January 23, 2001ASSIGNED TO EXAMINER